Kenneth E. Hook
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
-
- Cancer therapeutics and mechanisms
- Ubiquitin and proteasome pathways
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- Cancer therapeutics and mechanisms 4
- Ubiquitin and proteasome pathways 3
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 7
- Cancer-related Molecular Pathways 3
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Wilbur R. Leopold (5 shared papers)David W. Fry (4 shared papers)William A. Denny (2 shared papers)Annette M. Doherty (1 shared paper)Jeff B. Smaill (2 shared papers)Ellen M. Dobrusin (1 shared paper)Susanne Trumpp-Kallmeyer (1 shared paper)Alexander J. Bridges (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (2 papers)Investigational New Drugs (2 papers)Cancer Research (2 papers)International Journal of Cancer (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesNew ZealandFrance
In The Last Decade
Kenneth E. Hook
15 papers receiving 802 citations
Peers
Comparison fields: 5 of 76
- Oncology 312
- Molecular Biology 414
- Rheumatology 74
- Organic Chemistry 145
- Radiology, Nuclear Medicine and Imaging 101
Countries citing papers authored by Kenneth E. Hook
This map shows the geographic impact of Kenneth E. Hook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth E. Hook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth E. Hook more than expected).
Fields of papers citing papers by Kenneth E. Hook
This network shows the impact of papers produced by Kenneth E. Hook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth E. Hook. The network helps show where Kenneth E. Hook may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenneth E. Hook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 366 | |
| 2 | 2006 | 124 | |
| 3 | Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. | 2000 | 85 |
| 4 | 2012 | 82 | |
| 5 | 1995 | 56 | |
| 6 | 1985 | 39 | |
| 7 | 2013 | 31 | |
| 8 | 1995 | 13 | |
| 9 | In vivo and in vitro evaluation of the alkylating agent carmethizole. | 1991 | 10 |
| 10 | 2003 | 5 | |
| 11 | 1996 | 4 | |
| 12 | 1989 | 3 | |
| 13 | 2010 | 2 | |
| 14 | 2010 | 1 | |
| 15 | 2004 | 1 |
About Kenneth E. Hook
Kenneth E. Hook is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Organic Chemistry, having authored 15 papers that have together received 822 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Ubiquitin and proteasome pathways (3 papers), Microtubule and mitosis dynamics (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Treatment and Pharmacology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (312 citations), Molecular Biology (414 citations), Rheumatology (74 citations), Organic Chemistry (145 citations) and Radiology, Nuclear Medicine and Imaging (101 citations). Kenneth E. Hook has collaborated with scholars based in United States, New Zealand and France. Frequent co-authors include Wilbur R. Leopold, David W. Fry, William A. Denny, Annette M. Doherty, Jeff B. Smaill, Ellen M. Dobrusin, Susanne Trumpp-Kallmeyer, Alexander J. Bridges, James M. Nelson and Kenneth D. Greis. Their work appears in journals such as Molecular Cancer Therapeutics, Investigational New Drugs, Cancer Research, International Journal of Cancer and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.